Related Experiment Video
Updated: Aug 16, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen
Fuzhong F Zheng1, Ray-Chang Wu, Carolyn L Smith
1Molecular and Cellular Biology, One Baylor Plaza, Houston, TX 77030, USA.
Abstract:
SRC-3/AIB1/ACTR/pCIP/RAC3/TRAM1 is a primary transcriptional coregulator for estrogen receptor (ER). Six SRC-3 phosphorylation sites have been identified, and these can be induced by steroids, cytokines, and growth factors, involving multiple kinase signaling pathways. Using phosphospecific antibodies for six phosphorylation sites, we investigated the mechanisms involved in estradiol (E2)-induced SRC-3 phosphorylation and found that this occurs only when either activated estrogen receptor alpha (ERalpha) or activated ERbeta is present. Both the activation function 1 and the ligand binding domains of ERalpha are required for maximal induction. Mutations in the coactivator binding groove of the ERalpha ligand binding domain inhibit E2-stimulated SRC-3 phosphorylation, as do mutations in the nuclear receptor-interacting domain of SRC-3, suggesting that ERalpha must directly contact SRC-3 for this posttranslational modification to take place. A transcriptionally inactive ERalpha mutant which localizes to the cytoplasm supports E2-induced SRC-3 phosphorylation. Mutations of the ERalpha DNA binding domain did not block this rapid E2-dependent SRC-3 phosphorylation. Together these data demonstrate that E2-induced SRC-3 phosphorylation is dependent on a direct interaction between SRC-3 and ERalpha and can occur outside of the nucleus. Our results provide evidence for an early nongenomic action of ER on SRC-3 that supports the well-established downstream genomic roles of estrogen and coactivators.
Insights
Estradiol (E2) rapidly triggers SRC-3 phosphorylation via direct interaction with estrogen receptors (ERalpha/ERbeta), even in the cytoplasm. This early, nongenomic action precedes SRC-3
Area of Science:
- Molecular Biology
- Endocrinology
- Cell Signaling
Background:
- SRC-3 is a key transcriptional coregulator for estrogen receptors (ER).
- SRC-3 phosphorylation is induced by various signals, involving multiple kinase pathways.
- Six SRC-3 phosphorylation sites have been identified.
Purpose of the Study:
- To investigate the mechanisms of estradiol (E2)-induced SRC-3 phosphorylation.
- To determine the role of estrogen receptor (ER) subtypes and domains in SRC-3 phosphorylation.
- To explore the cellular localization and timing of E2-induced SRC-3 phosphorylation.
Main Methods:
- Utilized phosphospecific antibodies to detect SRC-3 phosphorylation at six sites.
- Employed site-directed mutagenesis of ERalpha and SRC-3 domains.
- Assessed SRC-3 phosphorylation in response to E2 with various ERalpha mutants.
Main Results:
- E2-induced SRC-3 phosphorylation requires activated ERalpha or ERbeta.
- Maximal phosphorylation induction needs ERalpha's activation function 1 and ligand-binding domains.
- Direct interaction between ERalpha and SRC-3 is essential for phosphorylation, which can occur in the cytoplasm.
Conclusions:
- E2-induced SRC-3 phosphorylation is dependent on direct ERalpha-SRC-3 interaction.
- This phosphorylation event represents an early, nongenomic ER action.
- The findings support the established genomic roles of estrogen and coactivators.
Related Concept Videos
Internal Receptors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
MAPK Signaling Cascades
Regulation of Nuclear Protein Sorting
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
TGF - β Signaling Pathway

